Vicente Guillermo Verez Bencomo

Title: Vicente Guillermo Verez Bencomo: Innovator in Vaccine Adjuvants

Introduction

Vicente Guillermo Verez Bencomo is a prominent inventor based in Havana, Cuba. He has made significant contributions to the field of immunology, particularly in the development of vaccine adjuvants. With a total of 2 patents, his work focuses on enhancing immune responses through innovative approaches.

Latest Patents

One of Vicente's latest patents involves the creation of nano-particles that contain synthetic variants of GM3 ganglioside as adjuvants in vaccines. This invention describes methods for obtaining nano-particulated adjuvants formed by different synthetic variants of GM3 ganglioside. Depending on the fine structure of the fatty acid in the ceramide of the synthetic GM3, these adjuvants can specifically stimulate the humoral or cellular immune response against accompanying antigens. The invention provides immunogenic vaccine compositions that include peptides, polypeptides, or proteins along with the aforementioned nanoparticles, which are formed through the dispersion of hydrophobic proteins of the outer membrane complex in solutions containing fully synthetic variants of the GM3 ganglioside.

Career Highlights

Vicente works at the Centro de Inmunología Molecular, where he continues to advance research in vaccine development. His innovative approaches have positioned him as a key figure in the field of immunology.

Collaborations

He collaborates with notable colleagues such as Luis Enrique Fernández Molina and Belinda Sánchez Ramírez, contributing to a dynamic research environment that fosters innovation.

Conclusion

Vicente Guillermo Verez Bencomo's work in developing vaccine adjuvants showcases his commitment to enhancing immunological responses through innovative technologies. His contributions are vital in the ongoing efforts to improve vaccine efficacy and public health.